Arcturus Therapeutics

📍 San Diego, United States🗓 Founded 2013👥 191 employees💰 Last funded Dec 2022
Biotechnology Research🌐 arcturusrx.com
Website LinkedIn
Arcturus Therapeutics is a global late stage-clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases
3
Total investors
0
Early stage
2
Mid stage
1
Late stage
2013
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
3
Investor activity2018–2022 · investors recorded per year
2018220221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Arcturus Therapeutics?
Arcturus Therapeutics has 3 investors on record on gritt.io, 2 mid-stage and 1 late-stage investors.
When did Arcturus Therapeutics last raise funding?
The most recent investment in Arcturus Therapeutics recorded on gritt.io was in December 2022.
When was Arcturus Therapeutics founded?
Arcturus Therapeutics was founded in 2013.
What industry is Arcturus Therapeutics in?
Arcturus Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Arcturus Therapeutics based?
Arcturus Therapeutics is headquartered in San Diego, United States.